Forth Therapeutics

News

Sofinnova Partners has raised €165m for its new biotech fund and backed three startups working on Alzheimer's, fibrotic diseases, and cell therapies.

News

Teva has made its first pipeline-building acquisition in almost a decade, buying Tourette syndrome drug developer Emalex for up to $900m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.